DATED 16 January 2024 GLAXO GROUP LIMITED and PFIZER INC. and GSK (NO.1) SCOTTISH LIMITED PARTNERSHIP and MERRILL LYNCH INTERNATIONAL and CITIGROUP GLOBAL MARKETS LIMITEDGSK PLC • January 19th, 2024 • Pharmaceutical preparations
SECONDARY BLOCK TRADE AGREEMENT, made on 16 January 2024 BETWEENSecondary Block Trade Agreement • January 19th, 2024 • GSK PLC • Pharmaceutical preparations
GSK (No.1) Scottish Limited Partnership (“SLP1”), a private fund limited partnership registered in Scotland with registration number SL035527 and whose principal place of business is at 50 Lothian Road, Festival Square, Edinburgh, EH3 9WJ;
TERMS OF SALESecondary Block Trade Agreement • January 19th, 2024 • GSK PLC • Pharmaceutical preparations
Further to the provisions of the SECONDARY BLOCK TRADE AGREEMENT DATED 16 January 2024 between GSK (No.1) Scottish Limited Partnership (“SLP1”), Merrill Lynch International and Citigroup Global Markets Limited (the “Agreement”), the following terms of sale are agreed:
